Results of two studies funded by Project A.L.S. and appearing in today’s advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig’s disease.
People with a family history of pancreas cancer now have a way to accurately predict their chance of carrying a gene for hereditary pancreas cancer and their lifetime risk of developing the disease.
deCODE genetics, Inc. (Nasdaq:DCGN) announced the launch of deCODE T2?, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
An international research team ? including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology ? has identified several novel genetic variations associated with the risk of Crohn’s disease.
By combining two techniques, magnetic resonance imaging (MRI) and near-infrared optics, researchers at Dartmouth College and Dartmouth Medical School may have devised a new, potentially more accurate method for diagnosing breast cancer.
The Honourable Tony Clement, Minister of Health, and the Honourable Jim Prentice, Minister of Indian Affairs and Northern Development and Federal Interlocutor for M?tis and Non-Status Indians, launched the first ever national food guide for First Nations, Inuit and M?tis – ?Eating Well with Canada’s Food Guide – First Nations Inuit and M?tis.?
A study of how the brain of a premature infant responds to injury has found vulnerabilities similar to those in the mature brain but also identified at least one significant difference, according to neuroscientists and neonatologists at Washington University School of Medicine in St. Louis.
The Internet offers a valuable opportunity for the public to screen themselves for depression. This is the conclusion of a study published today in BMC Psychiatry, which demonstrates that a Chinese online tool for assessing depression is both accurate and reproducible, and may offer a way to identify the growing number of people suffering from depression.
Measuring a man?s daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer.